| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/1995 | EP0650735A2 Kit and method for pretargeting |
| 05/03/1995 | EP0650722A2 Invasive particles with protein coating |
| 05/03/1995 | EP0650721A1 Cyclosporin soft capsule |
| 05/03/1995 | EP0650596A1 Compositions and methods for regulating cellular signal transducing systems |
| 05/03/1995 | EP0650522A1 Novel cyclophilins, associating proteins and uses |
| 05/03/1995 | EP0650498A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein |
| 05/03/1995 | EP0650494A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
| 05/03/1995 | EP0650374A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
| 05/03/1995 | EP0650371A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 05/03/1995 | EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 05/03/1995 | EP0650367A1 Blocking intercellular interactions with cd43 chimeric molecules |
| 05/03/1995 | EP0650366A1 Compositions and methods for treating wounds |
| 05/03/1995 | EP0650364A1 Purification of factor ix |
| 05/03/1995 | EP0644937A4 Therapeutic and diagnostic methods based on neurotrophin-4 expression. |
| 05/03/1995 | EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions |
| 05/03/1995 | EP0504202B1 Improved meningococcal polysaccharide conjugate vaccine |
| 05/03/1995 | EP0502997B1 Use of gamma-interferon for the manufacture of a medicament in the treatment of steroid dependent asthma |
| 05/03/1995 | EP0500605B1 Cosmetic deodorants |
| 05/03/1995 | EP0470144B1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
| 05/03/1995 | EP0458949B1 Stabilization of k1k2p pro |
| 05/03/1995 | EP0456724B1 Composition and method for treating benign prostatic hypertrophy |
| 05/03/1995 | EP0407544B1 Monoclonal antibody against protein c |
| 05/03/1995 | EP0406398B1 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 05/03/1995 | EP0379522B1 Uses of recombinant colony stimulating factor-1 |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/03/1995 | CN1102213A Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uese thereof |
| 05/03/1995 | CN1102124A Method for treating hepatitis B carriers with minimal disease |
| 05/02/1995 | US5412125 Dipeptidic amides derived from glycyl-serine as surfactants or hydrating agents and cosmetic, pharmaceutical or alimentary compositions containing the same |
| 05/02/1995 | US5412073 Polypeptides and DNA coding therefor |
| 05/02/1995 | US5411964 Phenylalanine-glycine compounds having anti-tumor activity, process for preparation thereof, and pharmaceutical composition containing said compounds |
| 05/02/1995 | US5411956 Lipolytic enzyme inhibitors |
| 05/02/1995 | US5411952 Ocular cyclosporine composition |
| 05/02/1995 | US5411951 Prolonged release of biologically active somatotropin |
| 05/02/1995 | US5411948 Use of host cell phospholipids for inhibiting microbial colonization |
| 05/02/1995 | US5411943 Hepatoma treatment with somatostatin analogs |
| 05/02/1995 | US5411942 Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma |
| 05/02/1995 | US5411941 Heterodimeric osteogenic factor |
| 05/02/1995 | US5411940 Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
| 05/02/1995 | US5411884 Monoclonal antibody L53 which recognizes a human tumor-associated antigen |
| 05/02/1995 | US5411882 Cytokine which mediates inflammation |
| 05/02/1995 | US5411871 Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties |
| 05/02/1995 | US5411860 Amplification of human MDM2 gene in human tumors |
| 05/02/1995 | CA2134707A1 Methods and compositions for retarding the aging process |
| 05/02/1995 | CA1335429C Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| 05/02/1995 | CA1335425C Antiviral or antibacterial compound and method of use |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/27/1995 | WO1995011312A1 Compositions for inhibition of intracellular transcription factors and methods therefor |
| 04/27/1995 | WO1995011309A2 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | WO1995011308A1 Mammal with enhanced liver expression of a transgene |
| 04/27/1995 | WO1995011303A1 Cntf family antagonists |
| 04/27/1995 | WO1995011302A1 Avian interferon genes, novel recombinant dna and proteins |
| 04/27/1995 | WO1995011301A1 P53-mediated apoptosis |
| 04/27/1995 | WO1995011260A1 Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained |
| 04/27/1995 | WO1995011259A1 Platelet-derived growth factor analogues |
| 04/27/1995 | WO1995011258A1 Growth factor heterodimers |
| 04/27/1995 | WO1995011257A1 Ks-laminin and methods of use |
| 04/27/1995 | WO1995011256A1 Conotoxin peptides |
| 04/27/1995 | WO1995011255A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
| 04/27/1995 | WO1995011221A1 Calcium receptor-active arylalkyl amines |
| 04/27/1995 | WO1995011048A2 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | WO1995011040A1 The cloning of duffy blood group antigen |
| 04/27/1995 | WO1995011039A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND α-TOCOPHEROL |
| 04/27/1995 | WO1995011038A1 Treatment of cytomegalovirus infection |
| 04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | WO1995011009A1 Method for preparing microspheres comprising a fluidized bed drying step |
| 04/27/1995 | WO1995010938A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 04/27/1995 | WO1995006726A3 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
| 04/27/1995 | DE4336641A1 Use of superoxide dismutase (SOD) for producing pharmaceuticals with an antiviral action |
| 04/27/1995 | DE4336343A1 Use of hydrolytic enzymes for prophylaxis of miscarriage in pregnant women with idiopathic recurrent abortion in the history |
| 04/27/1995 | CA2182958A1 Mammal with enhanced liver expression of a transgene |
| 04/27/1995 | CA2174621A1 Avian interferon genes, novel recombinant dna and proteins |
| 04/27/1995 | CA2173978A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | CA2173363A1 Ks-laminin and methods of use |
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | CA2173206A1 The cloning of duffy blood group antigen |
| 04/27/1995 | CA2173138A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
| 04/27/1995 | CA2134317A1 L-selectin cleavage site, methods of diagnosis and usage thereof |
| 04/26/1995 | EP0650053A1 Synthetic standard for immunoassays |
| 04/26/1995 | EP0649908A1 Uses of gap gene sequences |
| 04/26/1995 | EP0649906A1 Nucleotide sequences coding for a protein with urease activity |
| 04/26/1995 | EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria |
| 04/26/1995 | EP0649651A1 Soft gelatin capsule manufacture |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649603A1 Antioxidant food, antioxidant preparation and antioxidization method |
| 04/26/1995 | EP0649468A1 Soluble cr1 derivatives |
| 04/26/1995 | EP0649467A1 Self-stabilized oligonucleotides as therapeutic agents |
| 04/26/1995 | EP0649443A1 Oxazolone derived materials |
| 04/26/1995 | EP0649434A1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 04/26/1995 | EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 04/26/1995 | EP0649426A1 Inhibitors of retroviral proteases |
| 04/26/1995 | EP0649414A1 Opioid diarylmethylpiperazines and piperidines |
| 04/26/1995 | EP0649305A1 Benzimidazoles for alleviating stomach ulcers in swine |
| 04/26/1995 | EP0649277A1 Conserved victorin-binding vital protein |
| 04/26/1995 | EP0580782A4 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 04/26/1995 | EP0482076B1 Stable vaccine compositions containing interleukins |
| 04/26/1995 | EP0451190B1 Deletion analogues of magainin peptides |
| 04/26/1995 | EP0419513B1 Recombinant flagellin vaccines |
| 04/26/1995 | CN1101908A Angiotensin II antagonists |